New Delhi, India: The Drug Controller General of India (DCGI) has requested additional data on Bharat Biotech's COVID-19 vaccine, Covaxin, in order to administer it to children aged 2 to 12 years, sources said.

The development comes after the Subject Expert Committee discussed suggestions for the limited emergency use of Covaxin in children ages 2 to 12. As of now, no recommendations have been made, the source quoted.

As per reports, the Subject Expert Committee has recommended limited emergency use of Biological E's COVID-19 vaccine, Corbevax, in children aged 5-12 years during a meeting on Thursday. DCGI will now give its emergency usage authorization permission.

The Corbevax vaccination is now being given to youngsters between the ages of 12 and 14. The immunisation campaign for children aged 15 to 18 years old began on January 3 this year. Covaxin is being given to them.

On March 16, the drive was expanded to include children aged 12 to 14. Corbevax is being given to them. In India, children aged 12 and up are now receiving two COVID-19 immunization.

Uncontrolled corona in these states, lockdown will be imposed

Big disaster in India! Surprising revelation about Omicron

Threat of a new wave of Corona looms over children, know what experts say?